Skip to content

Intratracheal instillation of budesonide suspension versus normal saline on oxidative stress in neonates with meconium aspiration syndrome

Intratracheal instillation of budesonide suspension versus normal saline on oxidative stress in neonates with meconium aspiration syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076604
Enrollment
Unknown
Registered
2023-10-12
Start date
2018-01-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meconium aspiration syndrome

Interventions

the treatment group:the treatment group was given 2ml of budesonide for treatment
The control group:The control group was given 2ml of normal saline for treatment,

Sponsors

Huai'an Maternity and Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Full-term infants with meconium in the amniotic fluid; weight = 2.5 kg; (2) meconium could be detected or aspirated below the vocal cords following endotracheal intubation; (3) respiratory distress started within 6 h of birth; (4) signs of infiltration, hyperinflation or atelectasis by chest x-ray examination; (5) other possible causes of neonatal respiratory distress were excluded.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Premature or small for gestational age; (2) severe congenital malformation; (3) parents were unwilling to participate in the study; (4) neonates that died within 24 h or abandoned treatment. Guardians of all neonates included were informed and signed informed consent forms.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;length of oxygen inhalation;Total Oxidant State of Serum ;total antioxidant capacity;Oxidative stress index;

Secondary

MeasureTime frame
mortality;length of mechanical ventilation;

Countries

China

Contacts

Public ContactZhaojun Pan

Huai'an Maternity and Child Healthcare Hospital

1276684451@qq.com+86 138 0523 3269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026